N-cyclopropyl-5-ethynylpyrimidin-2-amine → N-Cyclopropyl-5-(2-(2-methyl-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-2-yl)phenyl)ethynyl)pyrimidin-2-amine
Reaction equation
[CH:1]1([NH:4][C:5]2[N:10]=[CH:9][C:8]([C:11]#[CH:12])=[CH:7][N:6]=2)[CH2:3][CH2:2]1.I[C:14]1[CH:15]=[C:16]([C:21]2[NH:25][C:24]3[CH:26]=[C:27]([CH2:30][N:31]4[CH2:36][CH2:35][N:34]([CH3:37])[CH2:33][CH2:32]4)[CH:28]=[CH:29][C:23]=3[N:22]=2)[CH:17]=[CH:18][C:19]=1[CH3:20]>>[CH:1]1([NH:4][C:5]2[N:6]=[CH:7][C:8]([C:11]#[C:12][C:14]3[CH:15]=[C:16]([C:21]4[NH:25][C:24]5[CH:26]=[C:27]([CH2:30][N:31]6[CH2:32][CH2:33][N:34]([CH3:37])[CH2:35][CH2:36]6)[CH:28]=[CH:29][C:23]=5[N:22]=4)[CH:17]=[CH:18][C:19]=3[CH3:20])=[CH:9][N:10]=2)[CH2:3][CH2:2]1Participants
Reactant 2
Product 1
Procedure
The title compound was synthesized from N-cyclopropyl-5-ethynylpyrimidin-2-amine (as prepared above) and 2-(3-iodo-4-methylphenyl)-6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazole (as prepared in Example 1) in a manner similar to that described for in Example 1. The title compound was obtained as a brown solid. Mp: 136-137° C.; 1H NMR (300 MHz, CDCl3) δ: 8.40 (2H, s), 8.21 (1H, s), 7.96-7.99 (1H, d, J=9.0 Hz), 7.52-7.55 (1H, d, J=9.0 Hz), 7.49-7.52 (1H, d, J=9.0 Hz), 7.23-7.26 (1H, d, J=9.0 Hz), 7.15-7.18 (1H, d, J=9.0 Hz), 5.81 (1H, s), 5.28 (1H, s), 3.57 (2H, s), 2.78 (1H, s), 2.55 (8H, brs), 2.46 (3H, s), 2.32 (3H, s), 0.83-0.87 (2H, m), 0.56 (2H, brs). HRMS (ESI-TOF+): m/z [M+H]+ calcd for C29H32N7: 478.2714. found: 478.2718.
Sources & evidence
- ORD record
- ord-73f5bc32a8d34f4295ca31ec136ee601
- Source dataset
- uspto-grants-2014_10
- Patent number
- US08859553B2
Reaction notes
Loading…